Development of a Universal Epitope-Based Influenza Vaccine and Evaluation of Its Effectiveness in Mice.

Vaccines (Basel) · 2022 · PMC9026828 · PMID 35455283

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A comparison of the protective effects of the rMVA-k1-k2 and rMVA-k5 + k2 vaccine variants showed that both the survival rate and viral titer when infected with H1N1 or H3N2 influenza viral strains were better for the rMVA-k1-k2 variant than for rMVA-k5 + k2, although the differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.